Inflammatory diseases influence the course of hair loss
Peer-Reviewed Publication
Updates every hour. Last Updated: 23-Jun-2025 04:10 ET (23-Jun-2025 08:10 GMT/UTC)
Asthma, atopic dermatitis or Hashimoto's thyroiditis as concomitant diseases are risk factors for clinical features associated with a poor prognosis in circular hair loss, also known as alopecia areata (AA). In patients with three atopic diseases, namely atopic dermatitis, asthma and rhinitis, the average age of onset of AA is about ten years earlier than in patients without chronic inflammatory comorbidities. This has now been established by researchers from the University Hospital Bonn (UKB) and the University of Bonn in a large cohort study of affected patients. Their results have now been published in the journal "Allergy".
Poor nutrition during pregnancy can have serious consequences for both maternal and child health. A new research collaboration – ‘Mother’s Micronutrient Supplement for Pregnancy and Lactation’ (MoMS) – between researchers in Kenya, Norway and Denmark aims to develop and test a new, improved dietary supplement to reduce incidences of low birth weight, improve maternal and child health, and enhance growth and cognitive development in children. MoMS is funded by the Bill & Melinda Gates Foundation and the Novo Nordisk Foundation with a total of DKK 68 million ($ 9.87 million / € 9.5 million).
Research led by Newcastle University, UK demonstrates that AI can determine the course and severity of aggressive skin cancers, such as Merkel cell carcinoma (MCC), to enhance clinical decision making by generating personalised predictions of treatment specific outcomes for patients and their doctors.
Even individuals whose symptoms do not yet meet the criteria for clinical depression benefit from therapeutic interventions. This conclusion comes from a new meta-study led by researchers from Munich and Magdeburg who analyzed data from 30 studies. Participants who received interventions were significantly less likely to develop clinical depression within the first year.
Continuing significant advancements in the field of xenotransplantation, surgeon-scientists from the University of Maryland School of Medicine provided an extensive analysis on the second patient in the world to receive a genetically-modified pig organ. Lawrence Faucette, 58, received a pig heart at the University of Maryland Medical Center in 2023 to treat his end-stage heart failure. He lived for 40 days before choosing to forgo additional treatment after the transplant began to fail due to rejection.
Artificial Intelligence (AI) could help doctors identify follicles that are most likely to lead to the birth of a baby during IVF treatment more precisely than current methods.